Skip to main content
. 2023 May 10;80(6):144. doi: 10.1007/s00018-023-04793-w

Table 3.

Characterization of VSMC phenotypic transformations regulated by lncRNAs and circRNAs in vascular remodeling for maintaining vascular homeostasis

ncRNAs Target gene Regulation category Physiological function Disease type References
lncRNA-PEBP1P2 CDK9 Repress VSMC proliferation, migration, and dedifferentiation Suppress neointima formation Coronary heart disease and carotid atherosclerotic [175]
lncRNA-CARMN Myocardin Maintain contractile phenotype of VSMC Suppress neointima formation Carotid artery injury [176]
lncRNA-PSR YBX1 Promote VSMC proliferation and migration Promote neointima formation Spontaneous hypertension [177]
lncRNA-MYOSLID MKL1 Promote VSMC differentiation and inhibit proliferation Amplify VSMC differentiation program / [178]
lncRNA-AK098656 MYH11/FN1 IncreaseVSMC proliferation and migration, elevate extracellular matrix proteins Narrow resistant arteries Spontaneous hypertension [179]
LncRNA- MRAK048635_P1 / Inhibit VSMC proliferation and migration and promote apoptosis Reduce vascular damage in hypertension Essential hypertension [180]
lncRNA-NEAT1 WDR5 Promote VSMC proliferation and migration Promote neointima formation Occlusive vascular diseases [181]
lncRNA-FOXC2_AS1 Akt/mTOR Promote VSMC proliferation, migration, and dedifferentiation Promote neointima formation / [182]
lncRNA-SENCR Myocardin Inhibit VSMC proliferation, migration and synthetic phenotype-related gene expression Suppress rupture of mice aortic media Aortic dissection [183]
circRNA-SATB2 SM22-α/STIM1 Promote VSMC proliferation and migration Promote neointima formation Coronary heart disease [184]
circRNA-ZXDC ABCC6 Increase VSMC proliferation and migration activity Increase MMD vessels intima thickness Moyamoya disease [185]
circ-COL1A1 miR-30a-5p/SMAD30 Promote VSMC proliferation and migration Promote human saphenous vein tissue growth Atherosclerosis [186]